Drug Approval | March 19, 2024
Carbogen Amcis (Shanghai) completed ANVISA Audit
A five-day inspection was concluded successfully with no critical and no major observations raised
A five-day inspection was concluded successfully with no critical and no major observations raised
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Women emerge as the cornerstone of this monumental undertaking
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
ANVISA issues CGMP to Concord Biotech’s Unit I
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Subscribe To Our Newsletter & Stay Updated
